本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

DICE Therapeutics, Inc.

47.55
0.0000
成交量:- -
成交额:2.07亿
市值:22.72亿
市盈率:-20.24
高:47.55
开:47.55
低:47.55
收:47.55
数据加载中...
2023/08/09

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2023/08/09

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2023/08/09

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2023/08/09

重要事件披露

Form 8-K - Current report
2023/08/09

交易所摘牌声明

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2023/08/09

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/08/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/06/23

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/06/23

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/06/21

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/06/20

重要事件披露

Form 8-K - Current report
2023/06/07

重要事件披露

Form 8-K - Current report
2023/05/11

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/11

重要事件披露

8-K - Current report
2023/05/05

关联方拟减持公告

144 - Report of proposed sale of securities
2023/05/03

关联方拟减持公告

144 - Report of proposed sale of securities
2023/05/03

关联方拟减持公告

144 - Report of proposed sale of securities
2023/05/03

关联方拟减持公告

144 - Report of proposed sale of securities
2023/03/29

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2023/03/15

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]